Transcription of GOOD DISTRIBUTION PRACTICES (GDP) FOR …
{{id}} {{{paragraph}}}
Working document RESTRICTED WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE GOOD DISTRIBUTION PRACTICES (GDP) FOR PHARMACEUTICAL PRODUCTS World Health Organization 2005 All rights reserved. This draft is intended for a restricted audience only, the individuals and organizations having received this draft. The draft may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means outside these individuals and organizations (including the organizations concerned staff and member organizations) without the permission of WHO.
Working document QAS/04.068/Rev.2 page 4 storage and distribution of such products. In some cases, however, a person or entity involved in the distribution of pharmaceutical products is only involved in and is responsible for certain
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}